Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Teva Pharmaceutical Industries Limited (TEVA) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call Transcript
01:23pm, Thursday, 05'th Dec 2024
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) 7th Annual Evercore ISI HealthCONx Healthcare Conference Call December 5, 2024 8:20 AM ET Company Participants Richard Francis - President and Chief
TEL AVIV, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) presented positive data from its Phase 3 SPACE study evaluating the efficacy and safety of
TEVA Stock Down 10% in a Month: Should You Buy the Dip?
04:01pm, Thursday, 28'th Nov 2024
Teva's reasonable valuation, an improving pipeline, and sales and profit growth potential are good enough reasons for those who own the stock to stay invested.
2 Generic Drug Stocks Ready to Surge in 2025
08:30am, Wednesday, 27'th Nov 2024
Generic and biosimilar drugs are often preferred over the brand name version due to their cheaper prices. Generics are exact duplicates of the branded counterparts, while biosimilars are "similar" and
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
06:00pm, Monday, 25'th Nov 2024
TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and Eric Hughes, Teva's Ex
Teva Pharmaceutical Industries Limited (TEVA) Jefferies London Healthcare Conference (Transcript)
10:25am, Tuesday, 19'th Nov 2024
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Jefferies London Healthcare Conference November 19, 2024 3:30 AM ET Company Participants Richard Francis - President & CEO Conference Call Participa
Teva to Present at the Jefferies London Healthcare Conference
04:30pm, Friday, 08'th Nov 2024
TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Jeffer
Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
10:46am, Friday, 08'th Nov 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase
09:50am, Thursday, 07'th Nov 2024
TEVA reports better-than-expected third-quarter results, beating both earnings and sales estimates. However, the stock declines 7%.
Teva Pharmaceutical Industries Limited (TEVA) Q3 2024 Earnings Call Transcript
11:42am, Wednesday, 06'th Nov 2024
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q3 2024 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants Richard Francis - President & CEO Eli Kalif - CFO Eric Hughes - He
Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 06'th Nov 2024
While the top- and bottom-line numbers for Teva Pharmaceutical Industries (TEVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some o
Teva Pharm CEO says will work productively with Trump administration
10:06am, Wednesday, 06'th Nov 2024
Teva Pharmaceutical Industries expects to work productively with the incoming Trump administration in the United States, chief executive Richard Francis said on Wednesday.
Teva Pharmaceutical third-quarter profit, revenue top estimates
07:27am, Wednesday, 06'th Nov 2024
Teva Pharmaceutical Industries reported a larger than expected rise in third-quarter profit, boosted by strong sales of copycat medicines and its branded drugs to treat migraines and Huntington's dise
For an accessible version of this Press Release, please visit www.tevapharm.com
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
04:00pm, Tuesday, 05'th Nov 2024
Let us look at five large biotech and generic drug companies, NVO, GILD, MRNA, VTRS and TEVA, which are gearing up for their earnings releases this week.
